MarketPeel
Insider Trading Intelligence
Pricing
…
MH

Marc H. Hedrick

PSTV
CHIEF EXECUTIVE OFFICER · PLUS THERAPEUTICS, INC. · CIK 0001203672
FILING MIX · LIFETIME79%/21%
BUYS
34
SELLS
9
TOTAL VALUE
$93.2K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
34,431
AVG SELL PX
$1.96
TRADE KIND
SHOWING 43 / 43
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Marc H. Hedrick, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+41.67%+4.44%+0.85%+3.59%-0.51%—
14d12+41.67%-1.47%+0.88%-2.36%-1.26%—
30d12+50.00%-3.37%+2.31%-5.68%-5.09%—
60d12+50.00%+2.77%+4.95%-2.18%-0.02%—
90d12+50.00%-0.52%+4.71%-5.22%-4.26%—
180d12+33.33%-10.71%+8.68%-19.39%-24.16%—
1y12+25.00%+25.13%+16.61%+8.52%-65.55%—
2y12(1 pending)+0.00%-25.93%+21.20%-47.13%-97.02%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PSTV · 34,431 shares · as of Jul 1, 2026
01,437,1272,874,2534,311,3805,748,506202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 34 buys / 9 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
6,387——34,431Jul 1, 2026Jul 1, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
SALE
Chief Executive Officer
1,986——153,598Jul 1, 2026Jul 1, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
8,066——42,497Jul 1, 2026Jul 1, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
SALE
Chief Executive Officer
6,387——163,650Jul 1, 2026Jul 1, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
1,986——44,483Jul 1, 2026Jul 1, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
SALE
Chief Executive Officer
8,066——155,584Jul 1, 2026Jul 1, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,834——23,834May 14, 2026May 18, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,834——170,037May 14, 2026May 18, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
SALE
Chief Executive Officer
201,632——3,655,075Apr 1, 2026Apr 1, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
159,681——499,468Apr 1, 2026Apr 1, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
SALE
Chief Executive Officer
201,632——701,100Apr 1, 2026Apr 1, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
SALE
Chief Executive Officer
159,681——3,856,707Apr 1, 2026Apr 1, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,419,582——2,419,582Feb 25, 2026Feb 27, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,419,582——4,016,388Feb 25, 2026Feb 27, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
159,681——339,787Jan 1, 2026Jan 2, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
SALE
Chief Executive Officer
159,681——1,596,806Jan 1, 2026Jan 2, 2026 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
159,681——180,106Oct 1, 2025Oct 3, 2025 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
SALE
Chief Executive Officer
159,681——1,756,487Oct 1, 2025Oct 3, 2025 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,748,506——5,748,506Aug 13, 2025Aug 15, 2025 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,916,168——1,916,168Aug 13, 2025Aug 15, 2025 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,916,168——1,916,168Aug 13, 2025Oct 3, 2025 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,748,506——5,748,506Aug 13, 2025Oct 3, 2025 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
400,489——400,489Feb 18, 2025Feb 20, 2025 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
197,595——197,595Sep 11, 2024Sep 12, 2024 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
8,000$1.23$9.8K20,425Sep 10, 2024Sep 11, 2024 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
12,255$2.04$25.0K12,425May 8, 2024May 10, 2024 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,510——24,510May 8, 2024May 10, 2024 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
94,012——94,012Feb 22, 2024Feb 26, 2024 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
SALE
Chief Executive Officer
2,068$1.96$4.1K170Nov 20, 2023Dec 15, 2023 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
483,824——483,824Feb 15, 2023Feb 17, 2023 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
5,000$0.65$3.2K33,580Jun 15, 2022Jun 16, 2022 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
5,000$0.69$3.5K26,080Apr 26, 2022Apr 27, 2022 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,500$0.68$1.7K28,580Apr 26, 2022Apr 28, 2022 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,500$1.66$4.1K21,080Oct 26, 2021Oct 27, 2021 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,771——200,771May 25, 2021May 27, 2021 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,183$2.28$5.0K18,580Apr 30, 2021May 2, 2021 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,500$2.50$6.3K16,397Mar 4, 2021Mar 5, 2021 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
88,314——88,314Feb 16, 2021Feb 18, 2021 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,500$1.99$5.0K13,867Dec 10, 2020Dec 14, 2020 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
2,200$2.14$4.7K11,367Nov 30, 2020Dec 2, 2020 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
4,000$2.58$10.3K9,167Aug 12, 2020Aug 13, 2020 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
140,000——140,000Jun 25, 2020Jun 29, 2020 ↗View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASE
Chief Executive Officer
5,000$2.10$10.5K5,167Jun 22, 2020Jun 23, 2020 ↗View →
Other insiders · PSTV
Loading peer insiders…
About this filer
CIK 0001203672
ROLE
Chief Executive Officer
PRIMARY
PSTV
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001203672DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback